ALK CEO expects favorable price
Two FDA approvals in a matter of days is not something you see every day, but that is the reality for the Danish allergy group ALK and commercial partner Merck & Co. – known as MSD outside of North America.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.